MediWound Ltd.
MediWound Ltd. (MDWD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDWD · as of Jun 8, 2026
Key Statistics
Explore MediWound Ltd. Data
mdwd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 100.0%
The MDWD analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $27.00, representing +85.44% upside from the current price of $14.56.
Competitors & Peers
mdwd competitorsMDWD
AARD
EPRX
GNFT
IVA
IVVDStock Performance
Full HistoryAbout MediWound Ltd.
MediWound Ltd. a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical…
what is mediwound ltd. · mdwd stock overview · mediwound ltd. company profile · who is mediwound ltd. ceo · mdwd NASDAQ · mediwound ltd. headquarters · mediwound ltd. business segments
About Stock Overview & Key Data
MediWound Ltd. (MDWD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 20, 2014. As of the latest trading session, MDWD stock price is $14.56, with a market capitalization of $157.6M. The stock has returned -32.39% over the past 12 months and -21.40% year-to-date.
According to 13 Wall Street analysts, the consensus rating for MediWound Ltd. stock is Buy, with an average 12-month price target of $27.00. In fiscal year 2025, MediWound Ltd. reported revenue of $17.0M and net income of -$23.9M. For detailed data — including MediWound Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MediWound Ltd. (MDWD) stock price is $14.56. The stock is traded on NASDAQ under the ticker symbol MDWD. The 52-week range is $13.54 – $22.09.